Intangible Assets (Details Narrative) |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017
USD ($)
|
Sep. 30, 2016
USD ($)
|
Sep. 30, 2017
USD ($)
Patents
|
Sep. 30, 2016
USD ($)
|
|
Intangible assets capitalized | $ 0 | $ 3,550,000 | $ 0 | $ 6,450,000 |
Impairment of intangible assets | 723,218 | 5,531,383 | 723,218 | 6,525,273 |
Amortization of intangible assets | $ 457,419 | $ 2,030,886 | $ 1,803,264 | $ 6,018,196 |
Patents [Member] | ||||
Number of patents | Patents | 170 | |||
Number of additional patents | Patents | 10,000 | |||
Minimum [Member] | ||||
Weighted average useful life, intangibles | 1 year | |||
Maximum [Member] | ||||
Weighted average useful life, intangibles | 16 years |
X | ||||||||||
- Definition Represents information pertaining to the number of additional patents for which the company has economic rights. No definition available.
|
X | ||||||||||
- Definition Represents information pertaining to the number of patents. No definition available.
|
X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|